Researchers developed and tested a new ocular surface frailty index (OSFI) for predicting dry eye symptoms after uneventful cataract surgery.

This week, a familiar name tops the annual list of best ophthalmology hospitals, a small study suggests vitamin B3 could improve visual function among glaucomatous eyes and Santen gains rights to a blepharoptosis drug outside of the United States.

This study is the first to report the clinical features of glaucoma associated with a TANK binding kinase (TBK1) gene duplication.

This week, a study suggests some low-carb diets may help combat glaucoma, an innovative reinnervation surgery for facial paralysis and CorNeat’s novel keratoprosthesis is cleared for clinical trials in Israel.

This article provides consensus guidelines to steer the treatment of patients with noninfectious uveitis during the COVID-19 pandemic.

This study investigated the association of parental myopia with refractive error and ocular biometry in multiethnic children aged 6 to 72 months.

This review highlights the current literature and best practice guidelines on the use of immunosuppression in the time of the COVID-19 pandemic.

The FDA has cleared a novel ophthalmic solution of oxymetazoline hydrochloride (Upneeq) for acquired blepharoptosis, making it the only approved therapy for the condition.

This study assessed whether postoperative facedown positioning improves outcomes for large macular holes.

This study used an unsupervised artificial intelligence (AI) model to quantify central visual field (VF) loss patterns in eyes with glaucoma.

The authors investigated whether ocular surface cells are susceptible to SARS-CoV-2, the virus that causes COVID-19.

This review investigated the role of social distancing, face masks and eye protection in preventing transmission of SARS-CoV-2 and other betacoronaviruses.

The authors discuss the appropriate personal protective equipment (PPE) requirements for surgeons as well as the usage, availability and rationing of materials during the COVID-19 pandemic.

This week, a patient with COVID-19 experiences orbital emphysema, scientists provide a peek into how hummingbirds distinguish colors and new studies challenge researchers’ understanding of retinitis pigmentosa 59.

This prospective, randomized clinical trial compared the efficacy and safety of 3 fragmentation patterns in eyes undergoing femtosecond laser-assisted cataract surgery (FLACS).

Researchers from Duke University assessed whether N95 respirators could be decontaminated using hydrogen peroxide vapor.

This retrospective study evaluated the features and outcomes of eyes with retinal vasculitis and inflammation after brolucizumab treatment for neovascular AMD.

This case study details 5 patients with nonremitting conjunctivitis that was the sole presenting sign and symptom of COVID-19.

This large retrospective study evaluated the outcomes of selective laser trabeculoplasty.

In this study, clinical and radiologic assessments of orbital lesions were compared against histopathologic diagnosis for concordance.

The American Medical Association (AMA) has elected David H. Aizuss, MD, to its board of trustees.

The incidence of retinal vasculitis and retinal vascular occlusion after brolucizumab injections are higher than originally reported, according to a post-hoc review of the phase 3 HAWK and HARRIER trials.

This study evaluated the feasibility of rapid training and fit testing health care workers to elastomeric half-mask respirators (EHMRs).

This study examined the use of neodymium laser in eyes with high IOP following Ex-Press filtration device implantation.

This week, researchers develop the most impressive bionic eye to date, DeepMind outperforms human experts in diagnosing AMD and a study reveals high levels of depression among ophthalmologists during the pandemic.